Search for a trial | Research with human participants

2 results

An Open-label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Inebilizumab in Pediatric Subjects with Neuromyelitis Optica Spectrum Disorder

Approved WMOPending

This study has been transitioned to CTIS with ID 2023-510007-22-00 check the CTIS register for the current data. NMOSD is associated with a high degree of disability and mortality, and there is a unmet medical need in children with this disease.…

A phase 3, randomized, double-blind, multicenter, placebo-controlled study of Inebilizumab efficacy and safety in IgG4-related disease

Approved WMORecruitment stopped

This study has been transitioned to CTIS with ID 2023-508290-81-00 check the CTIS register for the current data. Primary objective: To evaluate the efficacy of inebilizumab in reducing the risk of a disease flare in patients with IgG4-RD.Secondary…